Operating Lease, Right-of-Use Asset of Tonix Pharmaceuticals Holding Corp. from 31 Mar 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Tonix Pharmaceuticals Holding Corp. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Mar 2019 to 30 Sep 2025.
  • Tonix Pharmaceuticals Holding Corp. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $376,000, a 40% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Tonix Pharmaceuticals Holding Corp. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $376,000 -$252,000 -40% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 $438,000 -$254,000 -37% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $501,000 -$256,000 -34% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $565,000 -$259,000 -31% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 $628,000 -$453,000 -42% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $692,000 -$521,000 -43% 30 Jun 2024 10-Q 16 Aug 2024 2024 Q2
Q1 2024 $757,000 -$229,000 -23% 31 Mar 2024 10-Q 13 May 2024 2024 Q1
Q4 2023 $824,000 +$109,000 +15% 31 Dec 2023 10-K 18 Mar 2025 2024 FY
Q3 2023 $1,081,000 +$241,000 +29% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,213,000 +$273,000 +29% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $986,000 +$226,000 +30% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $715,000 -$199,000 -22% 31 Dec 2022 10-K 01 Apr 2024 2023 FY
Q3 2022 $840,000 -$228,000 -21% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $940,000 -$78,000 -7.7% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $760,000 -$161,000 -17% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $914,000 -$344,000 -27% 31 Dec 2021 10-K 13 Mar 2023 2022 FY
Q3 2021 $1,068,000 -$128,000 -11% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 $1,018,000 +$577,000 +131% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $921,000 +$640,000 +228% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $1,258,000 +$902,000 +253% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 $1,196,000 +$731,000 +157% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $441,000 -$139,000 -24% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $281,000 -$298,000 -51% 31 Mar 2020 10-Q 12 May 2020 2020 Q1
Q4 2019 $356,000 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $465,000 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $580,000 30 Jun 2019 10-Q 12 Aug 2019 2019 Q2
Q1 2019 $579,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.